This additive effect has also been observed in pancreatic and glioma models of cancer, where it was shown that GM-CSF vaccination induced expression of PD-1/PD-L1 and facilitated the action of anti-PD-1 therapy [161,162]. Here, PDCD1 is linked to glioma.